Shares of Strides Pharma Science surged 9.05% to Rs 1,044.10 during Thursday’s trading session after the pharmaceutical company announced the successful closure of a USFDA inspection at its flagship manufacturing facility in Bengaluru.
This positive development followed the US Food and Drug Administration (US FDA) issuing an Establishment Inspection Report (EIR) for the facility, bringing the regulatory inspection to a close.